Reine Allan 4
4 · Foghorn Therapeutics Inc. · Filed Aug 11, 2021
Insider Transaction Report
Form 4
Reine Allan
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Options (Right to buy)
2021-08-09+26,892→ 257,512 totalExercise: $3.72Exp: 2029-09-16→ Common Stock (26,892 underlying) - Exercise/Conversion
Common Stock
2021-08-09$3.72/sh+26,892$100,038→ 53,784 total
Footnotes (1)
- [F1]The option vested as to 25% of the underlying shares of common stock on September 16, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.